These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance]. Hu SE, Zhang YJ, Cui YM, Zhang HQ. Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428 [Abstract] [Full Text] [Related]
3. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL, Fox SB. Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244 [Abstract] [Full Text] [Related]
5. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer. Nakamura Y, Yasuoka H, Tsujimoto M, Yang Q, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K. Clin Cancer Res; 2003 Nov 01; 9(14):5313-7. PubMed ID: 14614015 [Abstract] [Full Text] [Related]
6. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM. Clin Cancer Res; 2005 Nov 15; 11(22):8063-9. PubMed ID: 16299237 [Abstract] [Full Text] [Related]
8. [Expression and clinical significance of VEGF-C and Flt-4 in tongue squamous cell carcinoma]. Li QL, Chen FJ, Zeng ZY, Yang AK, Wu QL, Zhang HZ, Hou JH. Ai Zheng; 2006 Feb 15; 25(2):235-40. PubMed ID: 16480594 [Abstract] [Full Text] [Related]
9. Role of vascular endothelial growth factor-C and -D mRNA in breast cancer. Teramoto S, Arihiro K, Koseki M, Kataoka T, Asahara T, Ohdan H. Hiroshima J Med Sci; 2008 Jun 15; 57(2):73-8. PubMed ID: 18717190 [Abstract] [Full Text] [Related]
10. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma. Tanigaki Y, Nagashima Y, Kitamura Y, Matsuda H, Mikami Y, Tsukuda M. Int J Mol Med; 2004 Sep 15; 14(3):389-95. PubMed ID: 15289890 [Abstract] [Full Text] [Related]
11. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer. Kawakami M, Furuhata T, Kimura Y, Yamaguchi K, Hata F, Sasaki K, Hirata K. Surgery; 2003 Mar 15; 133(3):300-8. PubMed ID: 12660643 [Abstract] [Full Text] [Related]
12. The association between vascular endothelial growth factor-C, its corresponding receptor, VEGFR-3, and prognosis in primary breast cancer: a study with 193 cases. Bando H, Weich HA, Horiguchi S, Funata N, Ogawa T, Toi M. Oncol Rep; 2006 Mar 15; 15(3):653-9. PubMed ID: 16465426 [Abstract] [Full Text] [Related]
13. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Saintigny P, Kambouchner M, Ly M, Gomes N, Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL, Bernaudin JF, Kraemer M. Lung Cancer; 2007 Nov 15; 58(2):205-13. PubMed ID: 17686546 [Abstract] [Full Text] [Related]
14. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer. Takizawa H, Kondo K, Fujino H, Kenzaki K, Miyoshi T, Sakiyama S, Tangoku A. Br J Cancer; 2006 Jul 03; 95(1):75-9. PubMed ID: 16755294 [Abstract] [Full Text] [Related]
15. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer. van Iterson V, Leidenius M, von Smitten K, Bono P, Heikkilä P. Am J Clin Pathol; 2007 Nov 03; 128(5):759-66. PubMed ID: 17951197 [Abstract] [Full Text] [Related]
16. Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer. Fukunaga S, Maeda K, Noda E, Inoue T, Wada K, Hirakawa K. Oncology; 2006 Nov 03; 71(3-4):204-11. PubMed ID: 17641542 [Abstract] [Full Text] [Related]
17. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. Zhang XH, Huang DP, Guo GL, Chen GR, Zhang HX, Wan L, Chen SY. BMC Cancer; 2008 Jan 13; 8():4. PubMed ID: 18190720 [Abstract] [Full Text] [Related]
18. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer. Nakamura Y, Yasuoka H, Tsujimoto M, Imabun S, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K. Breast Cancer Res Treat; 2005 May 13; 91(2):125-32. PubMed ID: 15868440 [Abstract] [Full Text] [Related]
19. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma]. Lu ZQ, Li HG, Xie DR, Zhang HZ, Shen XM, Zeng YJ, Zeng H. Ai Zheng; 2005 Sep 13; 24(9):1132-5. PubMed ID: 16159440 [Abstract] [Full Text] [Related]
20. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis]. Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C. Aktuelle Urol; 2007 Sep 13; 38(5):392-7. PubMed ID: 17907066 [Abstract] [Full Text] [Related] Page: [Next] [New Search]